Anteris Technologies Global Corp. (ASX:AVR)
9.69
+2.40 (32.92%)
At close: Jan 21, 2026
ASX:AVR Market Cap
ASX:AVR has a market cap or net worth of 402.91 million as of January 21, 2026. Its market cap has increased by 30.36% in one year.
Market Cap
402.91M
Enterprise Value
392.16M
Revenue
3.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.69
Market Cap Chart
Since June 27, 2011, ASX:AVR's market cap has increased from 985.19K to 402.91M, an increase of 40,796.67%. That is a compound annual growth rate of 51.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 303.12M | -4.77% |
| Dec 31, 2025 | 318.29M | 7.09% |
| Dec 31, 2024 | 297.22M | -12.90% |
| Dec 29, 2023 | 341.26M | 10.57% |
| Dec 30, 2022 | 308.62M | 114.65% |
| Dec 31, 2021 | 143.78M | 548.70% |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 85.10B |
| Pro Medicus | 19.76B |
| Cochlear | 17.57B |
| Sonic Healthcare | 11.40B |
| Ramsay Health Care | 8.43B |
| Ansell | 4.85B |
| Telix Pharmaceuticals | 3.82B |
| Mesoblast | 3.28B |